According to the 13th annual tuberculosis report of the WorldHealth Organization (WHO) — published on World TB Day,March 24, 2009 — there were an estimated 9.27 millionnew cases of tuberculosis worldwide in 2007 (see interactive graphic).1Although this figure represents an increase from 9.24 millionin 2006, the world population has also grown, making the numberof cases per capita a more useful measure of the problem; thisfigure peaked in 2004 at 142 per 100,000 and fell to 139 per100,000 in 2007. An estimated 1.32 million people who were notinfected with the human . . . [Full Text of this Article]
Source Information
Dr. Donald is an emeritus professor in the Department of Paediatrics and Child Health, and Dr. van Helden a professor and head of the Division of Molecular Biology and Human Genetics, Medical Research Council Centre for Molecular and Cellular Biology, National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Faculty of Health Sciences, University of Stellenbosch, Stellenbosch, South Africa.
This article has been cited by other articles:
Bravo, L. T. C., Tuohy, M. J., Ang, C., Destura, R. V., Mendoza, M., Procop, G. W., Gordon, S. M., Hall, G. S., Shrestha, N. K.
(2009). Pyrosequencing for Rapid Detection of Mycobacterium tuberculosis Resistance to Rifampin, Isoniazid, and Fluoroquinolones. J. Clin. Microbiol.
47: 3985-3990
[Abstract][Full Text]
Young, L. S.
(2009). Reconsidering Some Approved Antimicrobial Agents for Tuberculosis. Antimicrob. Agents Chemother.
53: 4577-4579
[Full Text]
Previous
Interactive Graphic
